Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma.
Yuxiang MaXi ChenAo WangHongyun ZhaoQingguang LinHua BaoYang ZhangShaodong HongWanxiangfu TangYan HuangYunpeng YangXue WuYang ShaoWenfeng FangLi ZhangPublished in: Journal for immunotherapy of cancer (2021)
Anti-PD-1 treatment provided promising clinical benefit in pretreated patients with R/M NPC. Copy number loss in either GZMB or GZMH genes was associated with reduced survival.